MAZZA, STEFANO
MAZZA, STEFANO
Universita' degli Studi di MILANO
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study
2021 S. Mazza, O.S.N. Piazza, F.S. Conforti, A. Fasci, A. Rimondi, B. Marinoni, V. Casini, C. Ricci, F. Munari, L. Pirola, P. Invernizzi, C. Girelli, G. Lupinacci, L. Pastorelli, F. Cavallaro, L. Ferraris, A. Colucci, A. Amato, G. Eugenio Tontini, M. Vecchi, G. Fiorino, F. Caprioli
Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease
2021 S. Mazza, F.S. Conforti, L.V. Forzenigo, N. Piazza, R. Berte, A. Costantino, M. Fraquelli, M. Coletta, J. Rimola, M. Vecchi, F. Caprioli
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak
2020 A. Rimondi, G.E. Tontini, S. Mazza, F. Caprioli, A. Sangiovanni, P. Lampertico, M. Vecchi
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
2020 S. Mazza, A. Sorce, F. Peyvandi, M. Vecchi, F. Caprioli
Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease
2020 G. Leccese, A. Bibi, S. Mazza, F. Facciotti, F. Caprioli, P. Landini, M. Paroni
Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
2020 F. Botti, S. Mazza, S. Costa, E. Farina, L. Baldari, M. Prati
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic
2020 A. Costantino, D. Noviello, S. Mazza, R. Berté, F. Caprioli, M. Vecchi
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy
2020 R. Berte', S. Mazza, M.R. Stefanucci, D. Noviello, S. Costa, C. Ciafardini, E. Mileti, M. Mapelli, S. Pasqualato, S. Pinto, A. Favale, M. Vecchi, M.F. Neurath, R. Atreya, M.C. Fantini, F. Facciotti, F. Caprioli
Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases
2020 M. Coletta, M. Paroni, M.F. Alvisi, M. De Luca, E. Rulli, S. Mazza, F. Facciotti, G. Lattanzi, F. Strati, S. Abrignani, M.C. Fantini, M. Vecchi, J. Geginat, F. Caprioli
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation
2019 F. Invernizzi, M. Iavarone, C. Zavaglia, S. Mazza, U. Maggi, L. Cesarini, B.B. Antonelli, A. Airoldi, M.A. Manini, A. Sangiovanni, G. Rossi, M.F. Donato, L.S. Belli, P. Lampertico
Previous colonic resection is a risk factor for surgical relapse in Crohn's disease
2019 M. Coletta, A. Zefelippo, S. Mazza, V. D'Abrosca, F. Botti, B. Oreggia, M. Prati, L. Boni, M. Vecchi, F. Caprioli
Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn's disease treated with anti-tumour necrosis factor antibodies
2018 S. Orlando, M. Fraquelli, M. Coletta, F. Branchi, A. Magarotto, C.B. Conti, S. Mazza, D. Conte, G. Basilisco, F. Caprioli
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study
2018 A. Viola, D. Pugliese, S. Renna, F. Furfaro, F. Caprioli, R. D'Incà, F. Bossa, S. Mazza, G. Costantino, M. Fantini, G. Fiorino, A. Alibrandi, A. Orlando, A. Armuzzi, W. Fries